MYC and liver disorder: Furthermore, mIHC analysis revealed a significantly elevated presence of hepatic MYC+ ECs and MMP12+ Mψ in cases of human DILI (including AILI and non‐AILI groups) compared to other liver diseases, highlighting the disease‐specific nature of the microenvironment (Figure 6E,F).